All blog items

Pediatric patients at Duke Children's Primary Care at Roxboro Street are receiving more than just a check-up during their visits to the doctor – they're also getting a book.

  Sensory neurons in the head and face tap directly into the brain’s emotional pathways Hate headaches? The distress you feel is not all in your -- well, head. People consistently rate pain of the head, face, eyeballs, ears and teeth as more disruptive, and more emotionally draining, than pain elsewhere in the body.

A physician scientist in the field of genetics and hematology, David Ginsburg has contributed substantially to advancing the understanding, diagnosis, and care of inherited and acquired coagulation disorders. His contributions have improved the understanding of the molecular basis of inherited bleeding and thrombotic disorders, genetic modifiers of bleeding and thrombotic risk, and the structure and function of blood coagulation factors and the regulation of hemostatic balance.

Diane Havlir is a pioneering leader in the fight against HIV/AIDS. She has developed groundbreaking studies of early treatments, including highly active antiretroviral therapy (HAART) to overcome HIV’s ability to mutate and become resistant to individual drugs. She is a leader in a research field that has transformed HIV from a fatal disease to one that can be managed as a chronic illness.

Allan Kirk is about as thoroughly steeped in Duke Blue as it is possible to be: the son of a Duke-trained biologist, he earned both his MD and PhD at Duke, did his residency in surgery at Duke (serving as chief resident), and eventually joined the faculty at Duke. He even married a Duke nurse, and his children were born at Duke. In all his roles at Duke, he has demonstrated the leadership, scientific and medical excellence, and vision that exemplify the institution’s traditions and goals.

Racial and ethnic minorities frequently encounter barriers when accessing health care, but radiation oncologist Karen Winkfield aims to change that, making it her mission to break down those barriers and become a champion for health equity for all.

Anna Mae Diehl is a pioneer and international leader in the field of liver growth and pathobiology. Colleagues describe her work as marked by persistence and inspiration. She has conducted seminal research in many areas, including liver regeneration, the role of cytokines in liver disease, and hepatocellular cancer.

Few people have played a more important a role in transforming Duke into a truly global institution than Michael Merson. An international leader in global health and the founding director of the Duke Global Health Institute, Merson has extended the reach of the university, including the School of Medicine, into the farthest corners of the planet.

The NIH has announced that there will be significant changes to its grant application forms (Forms-E) and application guide instructions for all human subjects research proposals with due dates on or after January 25, 2018. A high-level summary of these changes is available on the NIH website.  If correct forms are not used, applications will be rejected without review.

The Duke Biorepository and Precision Pathology Center (BRPC) will institute a new fee schedule beginning January 1, 2018 for Pathology Reviews.    This new fee schedule applies only to Pathology Reviews, which occur early in the IRB Review phase and are not included in BRPC study specific budget teams receive.  Pathology Review fees will be invoiced separately to the study team through CoreResearch@Duke.   Please note Pathology Review fees are waived if a Faculty Pathologist is a listed as a collaborator on the protocol.  The new fee sched